Homozygous Familial Hypercholesterolemia (HoFH) Latest Advances

An Improved Prognosis in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in LDL-Lowering Therapy.

Journal: Journal of atherosclerosis and thrombosis

Published: March 29, 2026

Comparison of Clinical Characterization and Therapeutic Strategies between Homozygous Familial Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia.

Journal: Journal of atherosclerosis and thrombosis

Published: March 29, 2026

Genetic dyslipidemias.

Journal: Annales d'endocrinologie

Published: March 22, 2026

The safety and efficacy of adeno-associated virus-mediated LDLR transfection in homozygous familial hypercholesterolemia

Journal: Zhonghua xin xue guan bing za zhi

Published: March 22, 2026

Hepatocyte-Specific Knockout of YAP Protects Against Atherosclerosis via Inhibition of ANGPTL3 in Mice.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: February 26, 2026

Update on genetics of familial hypercholesterolemia.

Journal: Current opinion in lipidology

Published: February 18, 2026

When Pigs Fly into Medicine: Navigating Ethical Challenges Posed by Animal-Derived Medical Products.

Journal: The Journal of clinical ethics

Published: February 16, 2026

Advanced therapy in familial hypercholesterolemia.

Journal: Canadian family physician Medecin de famille canadien

Published: February 12, 2026

Familial hypercholesterolemia in pregnancy.

Journal: Current opinion in endocrinology, diabetes, and obesity

Published: February 05, 2026

Novel Approaches to Lipid Management: Beyond Statins and PCSK9 Inhibitors.

Journal: Journal of clinical medicine research

Published: January 30, 2026

Advancing Obstetric Care: The Role of Targeted Next-Generation Sequencing in Pregnancies with Structurally Normal Fetuses.

Journal: Journal of the Chinese Medical Association : JCMA

Published: January 27, 2026

Lomitapide reduces viability and clonogenicity in hepatocellular carcinoma cells but enhances xenograft growth: The importance of the tumor microenvironment.

Journal: The Journal of pharmacology and experimental therapeutics

Published: January 12, 2026

Homozygous Familial Hypercholesterolemia (HoFH) Latest Advances

Find the Latest Research About Homozygous Familial Hypercholesterolemia (HoFH)

An Improved Prognosis in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in LDL-Lowering Therapy.

An Improved Prognosis in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in LDL-Lowering Therapy.

Comparison of Clinical Characterization and Therapeutic Strategies between Homozygous Familial Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia.

Comparison of Clinical Characterization and Therapeutic Strategies between Homozygous Familial Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia.

Genetic dyslipidemias.

Genetic dyslipidemias.

The safety and efficacy of adeno-associated virus-mediated LDLR transfection in homozygous familial hypercholesterolemia

The safety and efficacy of adeno-associated virus-mediated LDLR transfection in homozygous familial hypercholesterolemia

Hepatocyte-Specific Knockout of YAP Protects Against Atherosclerosis via Inhibition of ANGPTL3 in Mice.

Hepatocyte-Specific Knockout of YAP Protects Against Atherosclerosis via Inhibition of ANGPTL3 in Mice.

Update on genetics of familial hypercholesterolemia.

Update on genetics of familial hypercholesterolemia.

When Pigs Fly into Medicine: Navigating Ethical Challenges Posed by Animal-Derived Medical Products.

When Pigs Fly into Medicine: Navigating Ethical Challenges Posed by Animal-Derived Medical Products.

Advanced therapy in familial hypercholesterolemia.

Advanced therapy in familial hypercholesterolemia.

Familial hypercholesterolemia in pregnancy.

Familial hypercholesterolemia in pregnancy.

Novel Approaches to Lipid Management: Beyond Statins and PCSK9 Inhibitors.

Novel Approaches to Lipid Management: Beyond Statins and PCSK9 Inhibitors.

Advancing Obstetric Care: The Role of Targeted Next-Generation Sequencing in Pregnancies with Structurally Normal Fetuses.

Advancing Obstetric Care: The Role of Targeted Next-Generation Sequencing in Pregnancies with Structurally Normal Fetuses.

Lomitapide reduces viability and clonogenicity in hepatocellular carcinoma cells but enhances xenograft growth: The importance of the tumor microenvironment.

Lomitapide reduces viability and clonogenicity in hepatocellular carcinoma cells but enhances xenograft growth: The importance of the tumor microenvironment.